Skip to main content

Advertisement

Table 3 Odds ratios and 95% CrIs for mixed treatment comparisons of confirmed infection studies, all-cause mortality

From: Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis

Treatment Comparison Odds Ratio 95% Credible Interval
Caspofungin vs. Fluconazole 1.34 (0.65, 2.48)
Amphotericin B Deoxycholate vs. Fluconazole 1.14 (0.78, 1.62)
Amphotericin B Liposomal vs. Fluconazole 1.81 (0.71, 3.90)
Voriconazole vs. Fluconazole 0.90 (0.48, 1.53)
Micafungin vs. Fluconazole 1.73 (0.74, 3.49)
Anidulafungin vs. Fluconazole 0.67 (0.36, 1.14)
Itraconazole vs. Fluconazole 0.83 (0.11, 2.94)
Amphotericin B Deoxycholate vs. Caspofungin 0.92 (0.50, 1.54)
Amphotericin B Liposomal vs. Caspofungin 1.35 (0.77, 2.20)
Voriconazole vs. Caspofungin 0.72 (0.33, 1.38)
Micafungin vs. Caspofungin 1.28 (0.86, 1.85)
Anidulafungin vs. Caspofungin 0.56 (0.21, 1.22)
Itraconazole vs. Caspofungin 0.67 (0.08, 2.44)
Amphotericin B Liposomal vs. Amphotericin B Deoxycholate 1.58 (0.68, 3.17)
Voriconazole vs. Amphotericin B Deoxycholate 0.78 (0.49, 1.19)
Micafungin vs. Amphotericin B Deoxycholate 1.51 (0.72, 2.81)
Anidulafungin vs. Amphotericin B Deoxycholate 0.60 (0.29, 1.12)
Itraconazole vs. Amphotericin B Deoxycholate 0.72 (0.10, 2.50)
Voriconazole vs. Amphotericin B Liposomal 0.57 (0.21, 1.26)
Micafungin vs. Amphotericin B Liposomal 0.98 (0.67, 1.38)
Anidulafungin vs. Amphotericin B Liposomal 0.44 (0.13, 1.08)
Itraconazole vs. Amphotericin B Liposomal 0.53 (0.06, 2.02)
Micafungin vs. Voriconazole 2.02 (0.82, 4.18)
Anidulafungin vs. Voriconazole 0.81 (0.33, 1.68)
Itraconazole vs. Voriconazole 0.97 (0.12, 3.46)
Anidulafungin vs. Micafungin 0.45 (0.15, 1.05)
Itraconazole vs. Micafungin 0.54 (0.06, 2.02)
Itraconazole vs. Anidulafungin 1.34 (0.15, 5.05)